Two Sigma Investments, LP Global Blood Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $4.67 Million - $9.82 Million	144,041 Added 84.33%	314,839 $21.4 Million
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $5.96 Million - $9.99 Million	-267,282 Reduced 61.01%	170,798 $5.46 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $6.33 Million - $8.78 Million	246,575 Added 128.76%	438,080 $15.2 Million
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $4.77 Million - $7.71 Million	191,505 New	191,505 $5.61 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $7.17 Million - $15 Million	-171,922 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $7.86 Million - $14.1 Million	171,922 New	171,922 $13.7 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.